Abstract
Background
Merkel cell carcinoma (MCC) is a rare cutaneous malignancy with a high rate of nodal metastasis. Sentinel lymph node biopsy (SLNB) is used in MCC and other cancers to identify regional node micrometastases in patients with clinically negative nodes; however, whether SLN status is associated with recurrence or prognosis in MCC is unclear.
Methods
A statistical analysis was performed of 397 published cases of MCC with SLNB results from 22 reports and 6 new cases, in order to elucidate any correlation between SLN status and recurrence, and to determine false-negative rates for SLNB.
Results
Of these 403 cases, 128 (31.8 %) had positive SLNs; 16 of these 128 (12.5 %) developed recurrence (6 nodal, 10 distant). Of 275 patients with negative SLNs, 27 (9.8 %) developed recurrence (19 nodal, 8 distant). Patients with positive SLNs had a greater risk of distant metastasis (OR 2.82; P = 0.037; 95 % CI 1.089–7.347). The false-negative rate for SLNB in all 403 patients was 12.9 %. Use of the immunohistochemical approach to diagnosis of micrometastasis with anti-CK20 antibody did not affect the false-negative rate.
Conclusions
Patients with positive SLNs had a greater risk of distant metastasis in MCC; positive SLN was an important prognostic factor in MCC. Further studies using standardized, more-sensitive techniques to examine entire SLNs may decrease the false-negative rate, and improve the significance of SLNB in MCC.
Similar content being viewed by others
References
Gupta SG, Wang LC, Penas PF et al (2006) Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 142:685–690
Morton DL, Wanek L, Nizze JA et al (1991) Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 214:491–499 (discussion 9–501)
Messina JL, Reintgen DS, Cruse CW et al (1997) Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 4:389–395
Pfeifer T, Weinberg H, Brady MS (1997) Lymphatic mapping for Merkel cell carcinoma. J Am Acad Dermatol 37:650–651
Ames SE, Krag DN, Brady MS (1998) Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases. J Surg Oncol 67:251–254
Hill AD, Brady MS, Coit DG (1999) Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 86:518–521
Sian KU, Wagner JD, Sood R et al (1999) Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma. Ann Plast Surg 42:679–682
Kurul S, Mudun A, Aksakal N et al (2000) Lymphatic mapping for Merkel cell carcinoma. Plast Reconstr Surg 105:680–683
Wasserberg N, Schachter J, Fenig E et al (2000) Applicability of the sentinel node technique to Merkel cell carcinoma. Dermatol Surg 26:138–141
Zeitouni NC, Cheney RT, Delacure MD (2000) Lymphoscintigraphy, sentinel lymph node biopsy, and Mohs micrographic surgery in the treatment of Merkel cell carcinoma. Dermatol Surg 26:12–18
Allen PJ, Busam K, Hill AD et al (2001) Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer 92:1650–1655
Duker I, Starz H, Bachter D et al (2001) Prognostic and therapeutic implications of sentinel lymphonodectomy and S-staging in Merkel cell carcinoma. Dermatology 202:225–229
Rodrigues LK, Leong SP, Kashani-Sabet M et al (2001) Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol 45:303–308
Mehrany K, Otley CC, Weenig RH et al (2002) A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 28:113–117 discussion 7
Su LD, Lowe L, Bradford CR et al (2002) Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 46:661–666
Michl C, Starz H, Bachter D et al (2003) Sentinel lymphonodectomy in nonmelanoma skin malignancies. Br J Dermatol 149:763–769
Pan D, Narayan D, Ariyan S (2002) Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases. Plast Reconstr Surg 110:1259–1265
Blom A, Kolb F, Lumbroso J et al (2003) Significance of sentinel lymph node biopsy in Merkel cell carcinoma. Analysis of 11 cases. Ann Dermatol Venereol 130:417–422
Schmalbach CE, Lowe L, Teknos TN et al (2005) Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg 131:610–614
Maza S, Trefzer U, Hofmann M et al (2006) Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging 33:433–440
Ortin-Perez J, van Rijk MC, Valdes-Olmos RA et al (2007) Lymphatic mapping and sentinel node biopsy in Merkel’s cell carcinoma. Eur J Surg Oncol 33:119–122
Warner RE, Quinn MJ, Hruby G et al (2008) Management of merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol 15:2509–2518
Fields RC, Busam KJ, Chou JF et al (2011) Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol 18:2529–2537
Howle J, Veness M (2012) Sentinel lymph node biopsy in patients with Merkel cell carcinoma: an emerging role and the Westmead hospital experience. Australas J Dermatol 53:26–31
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474
Allen PJ, Bowne WB, Jaques DP et al (2005) Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 23:2300–2309
Lemos BD, Storer BE, Iyer JG et al (2010) Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 63:751–761
Chao C, Wong SL, Ross MI et al (2002) Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 184:520–524 (discussion 5)
Morton DL, Thompson JF, Cochran AJ et al (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307–1317
Testori A, De Salvo GL, Montesco MC et al (2009) Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol 16:2018–2027
Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A et al (2006) Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol 13:1655–1663
Jones EL, Jones TS, Pearlman NW et al (2013) Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg 16:1–6
Namikawa K, Yamazaki N (2011) Sentinel lymph node biopsy guided by indocyanine green fluorescence for cutaneous melanoma. Eur J Dermatol 21:184–190
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Shibayama, Y., Imafuku, S., Takahashi, A. et al. Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases. Int J Clin Oncol 20, 188–193 (2015). https://doi.org/10.1007/s10147-014-0685-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-014-0685-3